Clinical Insights
Expert video commentary and evidence-based perspectives from leading psychiatrists — with key takeaways you can apply in clinical practice.
Author Insight
▶ Video
Pregnenolone and Resting-State Amygdala Connectivity in Women With Major Depressive Disorder
November 20, 2026
E. Sherwood Brown, MD, and Francesca Filbey, PhD, describe the background for a neuroimaging study of pregnenolone in women with major depressive disorder. The video focuses on resting-state fMRI findings across placebo, 500 mg/day, and 800 mg/day pregnenolone conditions.
Original Research
▶ Video
Resting State Functional Connectivity in Women With Depression Following Pregnenolone Administration
November 18, 2026
Pregnenolone was associated with decreased connectivity between the amygdala and frontal pole, regions involved in emotional processing and cognitive control.
Expert Commentary
▶ Video
DT120 for Generalized Anxiety Disorder: Findings From Phase 2b and Phase III Trials
November 11, 2026
Lori Davis, MD, reviews clinical trial findings on DT120, an oral disintegrating tablet formulation of lysergide, for generalized anxiety disorder. She describes efficacy findings across a phase 2b trial and two phase III trials, along with the adverse events seen during the dosing day session.
Expert Commentary
▶ Video
Challenges in Psychedelic Research Trials for Anxiety and Mood Disorders
November 11, 2026
Lori Davis, MD, of the University of Alabama at Birmingham describes methodological and clinical challenges in psychedelic research trials for anxiety and mood disorders. She discusses functional unblinding, expectancy bias, safety monitoring, and open questions about durability and implementation.
Expert Commentary
▶ Video
Psychedelic Medicines in Psychiatry
November 11, 2026
Lori Davis, MD, of the University of Alabama at Birmingham describes the current research interest in psychedelics in psychiatry, including proposed mechanisms, dosing differences, and investigational clinical signals in mental health conditions.
JCP Podcast
🎧 Podcast
Margaret Sibley, PhD, on Fluctuating ADHD Across the Lifespan in the MTA Study
November 6, 2026
In this JCP Podcast episode, Margaret Sibley, PhD, discusses her article on fluctuating ADHD in the Multimodal Treatment of ADHD study. She describes how symptom trajectories, comorbidities, and environmental demands may shape adult ADHD presentations.
Academic Highlights
▶ Video
Establishing the Clinical Role of Digital Therapeutics in Major Depressive Disorder Treatment: A Consensus Panel Perspective
November 2, 2026
This consensus panel report discusses the clinical role of digital therapeutics in major depressive disorder, with four consensus statements on evaluating, selecting, and implementing them within stepped care, including bridge-to-care and augmentation.
Webinar
▶ Video
Muscarinic Approaches to Schizophrenia, Mechanism, EMERGENT Data, and Open Questions
October 28, 2026
In this video webinar, Ilan Melnick, MD, discusses muscarinic approaches to schizophrenia, including the proposed M1 and M4 mechanism, short-term and long-term EMERGENT trial findings, and the goal of improving and maintaining functionality.